COM(2004)737 EU - Regulation
Compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems

Please note

This page contains a limited version of this dossier in the Parlementaire Monitor.

1.

Key information

official title

Proposal for a Regulation of the European Parliament and of the Council on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with public health problems
 
Legal instrument Regulation
Decision making procedure ordinary legislative procedure (COD)
reference by COM-number i COM(2004)737 EN
Additional COM-numbers SEC(2004)1348
procedure number i 2004/0258(COD)
CELEX number i 52004PC0737

2.

Key dates

Document 29-10-2004
Online publication 29-10-2004
Decision 17-05-2006; Verordening 2006/816
Publication in Official Journal i 09-06-2006; Special edition in Romanian: Chapter 13 Volume 053,Special edition in Croatian: Chapter 13 Volume 063,Special edition in Bulgarian: Chapter 13 Volume 053,OJ L 157, 9.6.2006

3.

Related information

4.

Resulting legislation

 

5.

Full version

This page is also available in a full version containing the latest state of affairs, the summary of the European Parliament Legislative Observatory, the legal basis, the legal context, other dossiers related to the dossier at hand, the stakeholders involved (e.g. European Commission directorates-general, European Parliament committees, Council configurations and even individual EU Commissioners and Members of the European Parliament) and finally documents of the European Parliament, the Council of Ministers and the European Commission.

The full version is available for registered users of the EU Monitor by ANP and PDC Informatie Architectuur.

6.

EU Monitor

The EU Monitor enables its users to keep track of the European process of lawmaking, focusing on the relevant dossiers. It automatically signals developments in your chosen topics of interest. Apologies to unregistered users, we can no longer add new users.This service will discontinue in the near future.